A citation-based method for searching scientific literature

F Rousseau, J Bonaventure, L Legeai-Mallet, A Pelet, J M Rozet, P Maroteaux, M Le Merrer, A Munnich. Nature 1994
Times Cited: 650







List of co-cited articles
821 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia.
R Shiang, L M Thompson, Y Z Zhu, D M Church, T J Fielder, M Bocian, S T Winokur, J J Wasmuth. Cell 1994
921
73

Achondroplasia.
William A Horton, Judith G Hall, Jacqueline T Hecht. Lancet 2007
280
34

Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3.
P L Tavormina, R Shiang, L M Thompson, Y Z Zhu, D J Wilkin, R S Lachman, W R Wilcox, D L Rimoin, D H Cohn, J J Wasmuth. Nat Genet 1995
478
25

Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia.
Florence Lorget, Nabil Kaci, Jeff Peng, Catherine Benoist-Lasselin, Emilie Mugniery, Todd Oppeneer, Dan J Wendt, Sean M Bell, Sherry Bullens, Stuart Bunting,[...]. Am J Hum Genet 2012
104
24

Statin treatment rescues FGFR3 skeletal dysplasia phenotypes.
Akihiro Yamashita, Miho Morioka, Hiromi Kishi, Takeshi Kimura, Yasuhito Yahara, Minoru Okada, Kaori Fujita, Hideaki Sawai, Shiro Ikegawa, Noriyuki Tsumaki. Nature 2014
129
23


Postnatal soluble FGFR3 therapy rescues achondroplasia symptoms and restores bone growth in mice.
Stéphanie Garcia, Béatrice Dirat, Thomas Tognacci, Nathalie Rochet, Xavier Mouska, Stéphanie Bonnafous, Stéphanie Patouraux, Albert Tran, Philippe Gual, Yannick Le Marchand-Brustel,[...]. Sci Transl Med 2013
57
33

Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway.
Akihiro Yasoda, Yasato Komatsu, Hideki Chusho, Takashi Miyazawa, Ami Ozasa, Masako Miura, Tatsuya Kurihara, Tomohiro Rogi, Shoji Tanaka, Michio Suda,[...]. Nat Med 2004
265
18

Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse model.
Davide Komla-Ebri, Emilie Dambroise, Ina Kramer, Catherine Benoist-Lasselin, Nabil Kaci, Cindy Le Gall, Ludovic Martin, Patricia Busca, Florent Barbault, Diana Graus-Porta,[...]. J Clin Invest 2016
43
41

Fibroblast growth factor receptor 3 is a negative regulator of bone growth.
C Deng, A Wynshaw-Boris, F Zhou, A Kuo, P Leder. Cell 1996
837
17

Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfism.
Daniel J Wendt, Melita Dvorak-Ewell, Sherry Bullens, Florence Lorget, Sean M Bell, Jeff Peng, Sianna Castillo, Mika Aoyagi-Scharber, Charles A O'Neill, Pavel Krejci,[...]. J Pharmacol Exp Ther 2015
57
29

Achondroplasia is defined by recurrent G380R mutations of FGFR3.
G A Bellus, T W Hefferon, R I Ortiz de Luna, J T Hecht, W A Horton, M Machado, I Kaitila, I McIntosh, C A Francomano. Am J Hum Genet 1995
339
17

Achondroplasia.
Geneviève Baujat, Laurence Legeai-Mallet, Georges Finidori, Valérie Cormier-Daire, Martine Le Merrer. Best Pract Res Clin Rheumatol 2008
66
24

Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias.
Akihiro Yasoda, Hidetomo Kitamura, Toshihito Fujii, Eri Kondo, Naoaki Murao, Masako Miura, Naotetsu Kanamoto, Yasato Komatsu, Hiroshi Arai, Kazuwa Nakao. Endocrinology 2009
79
18

Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3.
J S Colvin, B A Bohne, G W Harding, D G McEwen, D M Ornitz. Nat Genet 1996
688
14

The population-based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US.
D K Waller, A Correa, Tuan M Vo, Y Wang, C Hobbs, P H Langlois, K Pearson, P A Romitti, G M Shaw, J T Hecht. Am J Med Genet A 2008
88
15

Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux.
Cynthia F Bartels, Hulya Bükülmez, Pius Padayatti, David K Rhee, Conny van Ravenswaaij-Arts, Richard M Pauli, Stefan Mundlos, David Chitayat, Ling-Yu Shih, Lihadh I Al-Gazali,[...]. Am J Hum Genet 2004
228
13

Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype.
Shunichi Murakami, Gener Balmes, Sandra McKinney, Zhaoping Zhang, David Givol, Benoit de Crombrugghe. Genes Dev 2004
200
13

Meclozine promotes longitudinal skeletal growth in transgenic mice with achondroplasia carrying a gain-of-function mutation in the FGFR3 gene.
Masaki Matsushita, Satoru Hasegawa, Hiroshi Kitoh, Kensaku Mori, Bisei Ohkawara, Akihiro Yasoda, Akio Masuda, Naoki Ishiguro, Kinji Ohno. Endocrinology 2015
29
44

Meclozine facilitates proliferation and differentiation of chondrocytes by attenuating abnormally activated FGFR3 signaling in achondroplasia.
Masaki Matsushita, Hiroshi Kitoh, Bisei Ohkawara, Kenichi Mishima, Hiroshi Kaneko, Mikako Ito, Akio Masuda, Naoki Ishiguro, Kinji Ohno. PLoS One 2013
28
42

FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway.
Takehiko Matsushita, William R Wilcox, Yuk Yu Chan, Aya Kawanami, Hülya Bükülmez, Gener Balmes, Pavel Krejci, Pertchoui B Mekikian, Kazuyuki Otani, Isakichi Yamaura,[...]. Hum Mol Genet 2009
74
16

A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3.
Y Wang, M K Spatz, K Kannan, H Hayk, A Avivi, M Gorivodsky, M Pines, A Yayon, P Lonai, D Givol. Proc Natl Acad Sci U S A 1999
167
12

Activating Fgfr3 Y367C mutation causes hearing loss and inner ear defect in a mouse model of chondrodysplasia.
Stéphanie Pannier, Vincent Couloigner, Nadia Messaddeq, Monique Elmaleh-Bergès, Arnold Munnich, Raymond Romand, Laurence Legeai-Mallet. Biochim Biophys Acta 2009
38
31

Achondroplasia: Development, pathogenesis, and therapy.
David M Ornitz, Laurence Legeai-Mallet. Dev Dyn 2017
83
14

A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain-of-function Fgfr3 mouse model.
Aurélie Jonquoy, Emilie Mugniery, Catherine Benoist-Lasselin, Nabil Kaci, Laurent Le Corre, Florent Barbault, Anne-Lise Girard, Yves Le Merrer, Patricia Busca, Laurent Schibler,[...]. Hum Mol Genet 2012
29
37

A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome.
Reha M Toydemir, Anna E Brassington, Pinar Bayrak-Toydemir, Patrycja A Krakowiak, Lynn B Jorde, Frank G Whitby, Nicola Longo, David H Viskochil, John C Carey, Michael J Bamshad. Am J Hum Genet 2006
86
12

Dwarfism and early death in mice lacking C-type natriuretic peptide.
H Chusho, N Tamura, Y Ogawa, A Yasoda, M Suda, T Miyazawa, K Nakamura, K Nakao, T Kurihara, Y Komatsu,[...]. Proc Natl Acad Sci U S A 2001
330
11

Health supervision for children with achondroplasia.
Tracy L Trotter, Judith G Hall. Pediatrics 2005
114
11

FGFR3 mutation causes abnormal membranous ossification in achondroplasia.
Federico Di Rocco, Martin Biosse Duplan, Yann Heuzé, Nabil Kaci, Davide Komla-Ebri, Arnold Munnich, Emilie Mugniery, Catherine Benoist-Lasselin, Laurence Legeai-Mallet. Hum Mol Genet 2014
34
32



Standard growth curves for achondroplasia.
W A Horton, J I Rotter, D L Rimoin, C I Scott, J G Hall. J Pediatr 1978
171
11


Mortality in achondroplasia study: a 42-year follow-up.
Julia Wynn, Terri M King, Michael J Gambello, D Kim Waller, Jacqueline T Hecht. Am J Med Genet A 2007
70
14

A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia.
G A Bellus, I McIntosh, E A Smith, A S Aylsworth, I Kaitila, W A Horton, G A Greenhaw, J T Hecht, C A Francomano. Nat Genet 1995
332
10

Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome.
D J Wilkin, J K Szabo, R Cameron, S Henderson, G A Bellus, M L Mack, I Kaitila, J Loughlin, A Munnich, B Sykes,[...]. Am J Hum Genet 1998
145
10

Achondroplasia: a comprehensive clinical review.
Richard M Pauli. Orphanet J Rare Dis 2019
82
12

C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia.
Ravi Savarirayan, Melita Irving, Carlos A Bacino, Bret Bostwick, Joel Charrow, Valerie Cormier-Daire, Kim-Hanh Le Quan Sang, Patricia Dickson, Paul Harmatz, John Phillips,[...]. N Engl J Med 2019
58
17

Cellular signaling by fibroblast growth factor receptors.
V P Eswarakumar, I Lax, J Schlessinger. Cytokine Growth Factor Rev 2005
9

A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos.
T Iwata, L Chen, C Li, D A Ovchinnikov, R R Behringer, C A Francomano, C X Deng. Hum Mol Genet 2000
157
9

Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis.
Pavel Krejci, Bernard Masri, Vincent Fontaine, Pertchoui B Mekikian, Maryann Weis, Herve Prats, William R Wilcox. J Cell Sci 2005
104
9

Gain-of-function mutation in FGFR3 in mice leads to decreased bone mass by affecting both osteoblastogenesis and osteoclastogenesis.
Nan Su, Qidi Sun, Can Li, Xiumin Lu, Huabing Qi, Siyu Chen, Jing Yang, Xiaolan Du, Ling Zhao, Qifen He,[...]. Hum Mol Genet 2010
64
14

Weight for age charts for children with achondroplasia.
J E Hoover-Fong, J McGready, K J Schulze, H Barnes, C I Scott. Am J Med Genet A 2007
34
26

Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome.
A O Wilkie, S F Slaney, M Oldridge, M D Poole, G J Ashworth, A D Hockley, R D Hayward, D J David, L J Pulleyn, P Rutland. Nat Genet 1995
674
9

Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis.
L Chen, R Adar, X Yang, E O Monsonego, C Li, P V Hauschka, A Yayon, C X Deng. J Clin Invest 1999
189
9

Intermittent PTH (1-34) injection rescues the retarded skeletal development and postnatal lethality of mice mimicking human achondroplasia and thanatophoric dysplasia.
Yangli Xie, Nan Su, Min Jin, Huabing Qi, Junbao Yang, Can Li, Xiaolan Du, Fengtao Luo, Bo Chen, Yue Shen,[...]. Hum Mol Genet 2012
33
27

Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification.
A L Delezoide, C Benoist-Lasselin, L Legeai-Mallet, M Le Merrer, A Munnich, M Vekemans, J Bonaventure. Mech Dev 1998
136
9

A novel homozygous mutation in FGFR3 causes tall stature, severe lateral tibial deviation, scoliosis, hearing impairment, camptodactyly, and arachnodactyly.
Periklis Makrythanasis, Samia Temtamy, Mona S Aglan, Ghada A Otaify, Hanan Hamamy, Stylianos E Antonarakis. Hum Mutat 2014
38
23

Mortality in achondroplasia.
J T Hecht, C A Francomano, W A Horton, J F Annegers. Am J Hum Genet 1987
125
9

A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene.
P L Tavormina, G A Bellus, M K Webster, M J Bamshad, A E Fraley, I McIntosh, J Szabo, W Jiang, E W Jabs, W R Wilcox,[...]. Am J Hum Genet 1999
116
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.